Showing results (331-340 of 443) with videos related to
Sort By:
Pageof 45
Lung Cancer (Amsterdam, Netherlands)|October 31, 2016
Expression of mesothelin in thymic carcinoma and its potential therapeutic significanceAnish Thomas, Yuanbin Chen, Arlene Berman, et al.Blood|March 1, 2018
Minimal residual hairy cell leukemia eradication with moxetumomab pasudotox: phase 1 results and long-term follow-upRobert J Kreitman, Martin S Tallman, Tadeusz Robak, et al.Frontiers in Oncology|December 13, 2018
Interactions Between Pseudomonas Immunotoxins and the Plasma Membrane: Implications for CAT-8015 Immunotoxin TherapyMonika Bokori-Brown, Jeremy Metz, Peter G Petrov, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2014
Phase II clinical trial of amatuximab, a chimeric antimesothelin antibody with pemetrexed and cisplatin in advanced unresectable pleural mesotheliomaRaffit Hassan, Hedy L Kindler, Thierry Jahan, et al.British Journal of Clinical Pharmacology|February 21, 2020
Population pharmacokinetics, efficacy, and safety of moxetumomab pasudotox in patients with relapsed or refractory hairy cell leukaemiaDenison Kuruvilla, Yen Lin Chia, Kemal Balic, et al.Mabs|July 24, 2012
High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screeningYen Phung, Wei Gao, Yan-Gao Man, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|April 26, 2019
Lipoprotein modulation of proteinuric renal injuryYohei Tsuchida, Jianyong Zhong, Tadashi Otsuka, et al.CVIR Oncology|December 22, 2025
Mapping drug distribution using CT imaging following direct tissue injection in ex vivo liver: informing clinical implementationRobert Morhard, Michal Mauda-Havakuk, Jose F Delgado, et al.Cancer Research|April 3, 2004
Human CTLs to wild-type and enhanced epitopes of a novel prostate and breast tumor-associated protein, TARP, lyse human breast cancer cellsSangKon Oh, Masaki Terabe, C David Pendleton, et al.Cancer Immunology, Immunotherapy : CII|June 5, 2009
New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapyVittore Cereda, Diane J Poole, Claudia Palena, et al.Pageof 45